Hims (HIMS): FY24 Q4 earnings call, Feb 24, 2025
No Kalshi or Polymarket word markets were listed for Hims’s Feb 24, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
4 matches for “Testosterone”; 4 quoted, at least 25 words apart.
…also enable us to expand into specialties such as menopausal support, low testosterone, and more. With this acquisition, we are elevating the personalization of care…
…by supporting our expansion into additional specialties such as menopause and low testosterone and pave the way for a greater breadth of personalized offerings inclusive…
…necessary to expand into other areas such as menopausal support and low testosterone in the future. Second, we are investing to expand capacity for a…
…you kind of mentioned menopause testing as well as low T or testosterone on them. Any thoughts on timing potentially for that offering? And then…
Agents: this page as TSV at /api/v1/appearances/hims:2025-02-24:earnings_call · words: /api/v1/brief?appearance=hims:2025-02-24:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP